AURA
Price
$6.43
Change
-$0.01 (-0.16%)
Updated
Aug 28 closing price
Capitalization
399.43M
69 days until earnings call
CYCCP
Price
$5.29
Change
+$0.19 (+3.73%)
Updated
Aug 28 closing price
Capitalization
N/A
Interact to see
Advertisement

AURA vs CYCCP

Header iconAURA vs CYCCP Comparison
Open Charts AURA vs CYCCPBanner chart's image
Aura Biosciences
Price$6.43
Change-$0.01 (-0.16%)
Volume$113.38K
Capitalization399.43M
Cyclacel Pharmaceuticals
Price$5.29
Change+$0.19 (+3.73%)
Volume$11.4K
CapitalizationN/A
AURA vs CYCCP Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. CYCCP commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and CYCCP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AURA: $6.43 vs. CYCCP: $5.29)
Brand notoriety: AURA and CYCCP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 64% vs. CYCCP: 159%
Market capitalization -- AURA: $399.43M vs. CYCCP: $0
AURA [@Biotechnology] is valued at $399.43M. CYCCP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileCYCCP’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • CYCCP’s FA Score: 1 green, 4 red.
According to our system of comparison, CYCCP is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 2 TA indicator(s) are bullish while CYCCP’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 2 bullish, 6 bearish.
  • CYCCP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CYCCP is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -0.62% price change this week, while CYCCP (@Biotechnology) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA (-21.776) and CYCCP (-22.814) have similar YTD gains . CYCCP has higher annual earnings (EBITDA): -10.41M vs. AURA (-107.51M). AURA has more cash in the bank: 177M vs. CYCCP (4.28M). CYCCP has less debt than AURA: CYCCP (10K) vs AURA (18.1M). CYCCP has higher revenues than AURA: CYCCP (10K) vs AURA (0).
AURACYCCPAURA / CYCCP
Capitalization399MN/A-
EBITDA-107.51M-10.41M1,033%
Gain YTD-21.776-22.81495%
P/E RatioN/AN/A-
Revenue010K-
Total Cash177M4.28M4,140%
Total Debt18.1M10K181,000%
FUNDAMENTALS RATINGS
CYCCP: Fundamental Ratings
CYCCP
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURACYCCP
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBBW2.040.45
+28.71%
Mobilicom Limited
IFRX1.170.17
+17.00%
InflaRx NV
PLUG1.630.01
+0.62%
Plug Power
RRX152.910.19
+0.12%
Regal Rexnord Corp
TWFG27.00-0.97
-3.47%
TWFG Inc

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with VRDN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.16%
VRDN - AURA
52%
Loosely correlated
-0.65%
IDYA - AURA
50%
Loosely correlated
-0.28%
BEAM - AURA
47%
Loosely correlated
-0.06%
MGTX - AURA
47%
Loosely correlated
+0.67%
DSGN - AURA
47%
Loosely correlated
+6.62%
More

CYCCP and

Correlation & Price change

A.I.dvisor tells us that CYCCP and VALN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCCP
1D Price
Change %
CYCCP100%
+3.73%
VALN - CYCCP
24%
Poorly correlated
+1.03%
SRPT - CYCCP
23%
Poorly correlated
+1.49%
AURA - CYCCP
21%
Poorly correlated
-0.16%
KZIA - CYCCP
21%
Poorly correlated
-1.02%
TECH - CYCCP
21%
Poorly correlated
-3.36%
More